What profit does Huada Gene rely on?

Huada Gene is a leading genome technology company in China, and its profit mainly comes from the following aspects:

1. Genetic testing service: BGI provides genetic testing products and services, including individual genome testing, tumor gene testing and genetic disease testing. These testing services can provide individuals with genome-based health management and disease risk assessment, as well as doctors' personalized treatment programs. Genetic testing service is one of BGI's most profitable businesses.

2. Biomedical R&D cooperation: BGI cooperates with pharmaceutical enterprises and scientific research institutions to develop biomedical R&D. Huada Gene can provide services such as gene sequencing, bioinformatics analysis and biological sample processing for partners, and support cooperative projects in the fields of drug research and development and precision medical care. The income from these cooperative projects is also an important source of profit for BGI.

3. biochip and equipment sales: BGI produces and sells various biochips and equipment, which are mainly used in gene sequencing, bioinformatics analysis and other fields. BGI's biochips and equipment are widely used all over the world, and sales revenue is also an important part of its profits.

4. Genetic data service: BGI has accumulated a large number of genomic data and clinical data, and can provide genetic data analysis and interpretation services for academic research institutions and medical institutions. These genetic data services have also brought some income to BGI.

Generally speaking, BGI makes profits through genetic testing services, biomedical research and development cooperation, biochip and equipment sales and genetic data services. The combination of these businesses makes BGI more competitive in the field of genome science and technology.